|
1
|
Studeny M, Marini FC, Dembinski JL,
Zompetta C, Cabreira-Hansen M and Bekele BN: Mesenchymal stem
cells: potential precursors for tumor stroma and targeted-delivery
vehicles for anticancer agents. J Natl Cancer Inst. 96:1593–1603.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Horwitz EM, Prockop DJ, Fitzpatrick LA,
Koo WW, Gordon PL and Neel M: Transplantability and therapeutic
effects of bone marrow-derived mesenchymal cells in children with
osteogenesis imperfecta. Nat Med. 5:309–313. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Beachy PA, Karhadkar SS and Berman DM:
Tissue repair and stem cell renewal in carcinogenesis. Nature.
432:324–331. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fierro FA, Sierralta WD, Epuñan MJ and
Minguell JJ: Marrow-derived mesenchymal stem cells: role in
epithelial tumor cell determination. Clin Exp Metastas. 21:313–319.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu W, Xu W, Jiang R, Qian H, Chen M, Hu
J, Cao W, Han C and Chen Y: Mesenchymal stem cells derived from
bone marrow favor tumor cell growth in vivo. Exp Mol Pathol.
80:267–274. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Karnoub AE, Dash AB, Vo AP, Sullivan A,
Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R and Weinberg
RA: Mesenchymal stem cells within tumour stroma promote breast
cancer metastasis. Nature. 449:557–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Reyes M, Dudek A, Jahagirdan B, Koodie L,
Marker PH and Verfaillie CM: Origin of endothelial progenitors in
human postnatal bone marrow. J Clin Invest. 109:337–346. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Djouad F, Plence P, Bony C, Tropel P,
Apparailly F, Sany J, Noël D and Jorgensen C: Immunosuppressive
effect of mesenchymal stem cells favors tumor growth in allogeneic
animals. Blood. 102:3837–3844. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Portolani N, Coniglio A, Ghidoni S,
GiovanellMi A, Benetti G and Tiberio A: Early and late recurrence
after liver resection for hepatocellular carcinoma: prognostic and
therapeutic implications. Ann Surg. 243:229–235. 2006. View Article : Google Scholar
|
|
10
|
Ye QH, Qin LX, Forgues M, He P, Kim JW and
Peng AC: Predicting hepatitis B virus-positive metastatic
hepatocellular carcinomas using gene expression profiling and
supervised machine learning. Nat Med. 9:416–423. 2003. View Article : Google Scholar
|
|
11
|
Alison MR and Lovell MJ: Liver cancer: the
role of stem cells. Cell Prolif. 38:407–421. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vassilopoulos G, Wang PR and Russell DW:
Transplanted bone marrow regenerates liver by cell fusion. Nature.
422:901–904. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang X, Willenbring H, Akkari Y, Torimaru
Y, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Olson S and
Grompe M: Cell fusion is the principal source of
bone-marrow-derived hepatocytes. Nature. 422:897–901.
2003.PubMed/NCBI
|
|
14
|
Li GC, Ye QH, Xue YH, Sun HJ, Zhou HJ, Ren
N, Jia HL, Shi J, Wu JC, Dai C, Dong QZ and Qin LX: Human
mesenchymal stem cells inhibit metastasis of a hepatocellular
carcinoma model using the MHCC97-H cell line. Cancer Sci.
101:2546–2553. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nygren JM, Jovinge S, Breitbach M, Säwén
P, Röll W, Hescheler J, Taneera J, Fleischmann BK and Jacobsen SE:
Bone marrow-derived hematopoietic cells generate cardiomyocytes at
a low frequency through cell fusion, but not transdifferentiation.
Nat Med. 10:494–501. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen EH, Grote E, Mohler W and Vignery A:
Cell-cell fusion. FEBS Lett. 581:2181–2193. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ying QL, Nichols J, Chambers I and Smith
A: BMP induction of Id proteins suppresses differentiation and
sustains embryonic stem cell self-renewal in collaboration with
STAT3. Cell. 115:281–292. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Y, Tang Y, Ye L, Liu B, Liu K and Chen
J: Establishment of a hepatocellular carcinoma cell line with
unique metastatic characteristics through in vivo selection and
screening for metastasis-related genes through cDNA microarray. J
Cancer Res Clin Oncol. 129:43–51. 2003.
|
|
19
|
Li Y, Tang ZY, Ye SL, Liu YK, Chen J and
Xue Q: Establishment of cell clones with different metastatic
potential from the metastatic hepatocellular carcinoma cell line
MHCC97. World J Gastroenterol. 7:630–636. 2001.PubMed/NCBI
|
|
20
|
Sato Y, Araki H, Kato J, Nakamura K,
Kawano Y, Kobune M, Sato T, Miyanishi K, Matsuura A, Hamada H and
Niitsu Y: Human mesenchymal stem cells xenografted directly to rat
liver are differentiated into human hepatocytes without fusion.
Blood. 106:756–763. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kozorovitskiy Y and Gould E: Stem cell
fusion in the brain. Nat Cell Biol. 5:952–954. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang X, Willenbring H and Akkari Y: Cell
fusion is the principal source of bone-marrow-derived hepatocytes.
Nature. 42:2897–2901. 2003.
|
|
23
|
Alvarez-Dolado M, Pardal R, Garcia-Verdugo
JM, Fike JR, Lee HO, Pfeffer K, Lois C, Morrison SJ and
Alvarez-Buylla A: Fusion of bone-marrow-derived cells with Purkinje
neurons, cardiomyocytes and hepatocytes. Nature. 425:968–973. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Menthena A, Deb N, Oertel M, Grozdanov PN,
Sandhu J, Shah S, Guha C, Shafritz DA and Dabeva MD: Bone marrow
progenitors are not the source of expanding oval cells in injured
liver. Stem Cells. 22:1049–1061. 2004.PubMed/NCBI
|
|
25
|
Kaplan RN, Riba RD, Zacharoulis S, Bramley
AH, Vincent L, Costa C, Daniel DM, Ruggero D and Shmelkov SV:
VEGFR1-positive haematopoietic bone marrow progenitors initiate the
pre-metastatic niche. Nature. 438:820–827. 2005. View Article : Google Scholar
|
|
26
|
Ball SG, Shuttleworth AC and Kielty CM:
Circulating fibrocytes: collagen-secreting cells of the peripheral
blood. Int J Biochem Cell Biol. 36:598–606. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Iakova P, Awad SS and Timchenko NA: Aging
reduces proliferative capacities of liver by switching pathways of
C/EBPalpha growth arrest. Cell. 113:495–506. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wagemaker G, Neelis KJ and Wognum AW:
Surface markers and growth factor receptors of immature hemopoie
tic stem cell subsets. Stem Cells. 13(Suppl 1): 165–171.
1995.PubMed/NCBI
|
|
29
|
Zheng YW and Taniguchi H: Diversity of
hepatic stem cells in the fetal and adult liver. Semin Liver Dis.
23:337–348. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Goldsborough MD, Tilkins ML, Price PJ,
Lobo-Alfonso J, Morrison JR and Stevens ME: Serum-free culture of
murine embryonic stem (ES) cells. Focus. 20:8–12. 1998.
|
|
31
|
Desmouliere A, Guyot C and Gabbiani G: The
stroma reaction myofibroblast: a key player in the control of tumor
cell behavior. Int J Dev Biol. 48:509–517. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
De Wever O and Mareel M: Role of tissue
stroma in cancer cell invasion. J Pathol. 200:429–447.
2003.PubMed/NCBI
|
|
33
|
Direkze NC and Alison MR: Bone marrow and
tumour stroma: an intimate relationship. Hematol Oncol. 24:189–195.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Littlepage LE, Egeblad M and Werb Z:
Coevolution of cancer and stromal cellular responses. Cancer Cell.
7:499–500. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Welm AL: TGFbeta primes breast tumor cells
for metastasis. Cell. 33:27–28. 2008. View Article : Google Scholar : PubMed/NCBI
|
